hrsg. von Ernest Jucker
Founded in 1959, this series encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Invited authors present their biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxilogical, pharmacological and clinical expertise in written reviews and provide the newcomer and the specialist alike with an up-to-date list of references. This volume contains six reviews by recognized experts. They offer the reader information on: developments in research on histamine (H1) receptor agonists; antifungal chemotherapy; the diversity of heterocyclic compounds and their biological activities; newer antifolate compounds in cancer therapy; non-steroidal agents for regulation of the menstrual cycle; and developments in anti-convulsant drugs.
「Nielsen BookData」より
From the contents: A- C. Brater and M. D. Murray: The effects of NSAIDs on the kidney A- G. Edwards and A. H. Weston: Latest developments in potassium channel modulator drugs A- M.R. Juchau and Y. Huang: Chemical teratogenesis in humans: Biochemical and molecular mechanisms A- S.P. Gupta: Studies on cardiovascular drugs A- G. Polak: Antifungal chemotherapy: An everlasting battle A- O. Valdenaire: New insights into the bioamine receptor family
「Nielsen BookData」より
Progress in Drug Research is a prestigious book series (founded in 1959) which provides extensive expert-written reviews on a wide spectrum of highly topical areas in current pharmaceutical and pharmalogical research. Each volume contains fully cross-referencing indexes which link the volumes together, forming a virtually encyclopaedic work. The series thus serves as an important, time-saving source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.<p>Volume 50 in the series includes: <p>P.N. Kaul: Drug discovery: Past, present and future<p>M. Rohmer: Isoprenoid biosynthesis via the mevalonate -- independent route, a novel target for antibacterial drugs<p>G. Edwards and A.H. Weston: Endothelium, -derived hyperpolarizing factor -- a critical appraisal<p>R.W. Rockhold: Glutamatic involvement in psychomotor stimulant action<p>J.M. Colacino and K.A. Staschke: The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection<p>T.D. Johnson: Polyamines and cerebral ischemia
「Nielsen BookData」より
This is Volume 42 in a series featuring reviews on a wide spectum of topical areas in current pharmaceutical and pharmacological research. Founded in 1959, the series has moved from its initial focus on medicinal chemistry to a much wider scope. Today, it aims to encompass all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Invited authors present their biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxicological, pharmacological and clinical expertise in written reviews, providing the newcomer and specialist alike with an up-to-date list of prime references. Each volume of "Progress in Drug Research" contains fully cross-referencing indexes which link the books together.
「Nielsen BookData」より
This series provides expert-written reviews on a wide spectrum of topical areas in pharmacological and pharmaceutical research. It encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Each volume is cross-referenced to the others in the series. Topics covered in this volume include: cholesterol-lowering drugs and drugs for other metabolic disorders involving lipids; the progress achieved since the 1940s in the search for ideal antihypertensive drugs; natural polyamines and their role in the immune system; biologically active quinazolones, a class of chemically related substances with a wide range of different effects; and recent advances in research on gene regulation and expression of interferons.
「Nielsen BookData」より
This series was founded in 1959, and its focus has shifted from medicinal chemistry to a much wider scope. It now encompasses all fields concerned with the development of therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drugs research. Invited authors write reviews on the following fields: biology, chemistry, biochemistry, physiology, immunology, pharmacy, toxicology, pharmacology, and clinical aspects. The books are linked by indexes in each volume, forming an almost encyclopaedic work.
「Nielsen BookData」より
This text is part of a series which encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of the mechanisms of action, reflecting the increasingly complex nature of modern drug research. In this collection, papers discuss biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxicological, pharmacological and clinical areas in an attempt to keep abreast of the many developments in the quest for new and better medicines.
「Nielsen BookData」より
Volume 46 of this well-established and acclaimed book series contains seven comprehensive reviews by internationally recognized experts. They will provide the reader with up-to-date information. Contents: N.K. Hollenberg and S.W. Graves: Endogenous sodium pump inhibition: Current Status a [ R.B. McCall: Neurotransmitters involved in the central regulation of the cardivascular system a [ W.T. Jackson and J.H. Fleisch: Development of novel anti- inflammatory agents: A pharmacologic perspective on leukotrienes and their receptors a [ M. Margaglione, E. Grandone, F.P. Mancini and G. Di Minno: Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies a [ N. Seiler, A. Hardy and J.P. Moulinoux: Aminoglycosides and polyamines: Targets and effects in the mammalian organism of two important groups of natural aliphatic polycations a [ J. Claghorn and M.D. Lesem: Recent developments in antidepressant agents a [ E.J. Lien, A. Das and L.L. Lien: Immunopharmacological and biochemical bases of Chinese herbal medicine a [ Index Vol. 46 a [ Index of titles Vols. 1-46 a [ Author and paper index Vols. 1-46
「Nielsen BookData」より
The Series Progress in Drug Research was founded by its current editor in 1959 for the purpose of providing review articles on topical areas of pharmaceutical research. In the beginning, during the "Golden Age" of drug discoveries, these surveys were chiefly focused on chemical pharmacological and preclinical investigations. Gradually, the search for new medicines c increasingly complex as new disciplines entered the research arena augmenting or even partly replacing the traditional research. fields. The more recent volumes of Progress m Drug Research contain mainly review articles on biochemical, biological, immunological, physiological Clinical and medicinal of drug research. The Contents of the recent volumes demonstrate the complex nature of today's search for new medicines. The 40 volumes of Progress in Drug Research so far available contain over 440 review articles, innumerable references to original publications, as well as extensive indexes.
Researchers who are actively engaged in the various scientific branches of drug research will be greatly assisted in their own work by the comprehensive surveys and will certainly profit from the vast experience of the respective authors. Those who want to keep abreast of new developments in this area, without the burden of reading innumerable original papers, will certainly appreciate the almost encyclopedic nature of this series.
「Nielsen BookData」より